{
  "id": 2355253,
  "title": "Wolfe Research reiterates Lumentum stock rating on M&A potential",
  "url": "https://urgent.news/2026/08/21/wolfe-research-reiterates-lumentum-stock-rating-on-m-a-potential",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-21T10:02:52.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/analyst-ratings/wolfe-research-reiterates-lumentum-stock-rating-on-ma-potential-93CH-4871200"
  },
  "original_language": "en",
  "account": "Wolfe Research has maintained an Outperform rating on Lumentum Holdings (NASDAQ:LITE) with a price target of $1,200.00, citing potential M&A opportunities. The stock has experienced a remarkable surge of 649% over the past year, currently trading at $879.28. However, analysts note that the shares are potentially overvalued relative to their Fair Value estimate. Despite this, 20 analysts have recently revised their earnings estimates upward, reflecting confidence in the company. Lumentum's recent filings indicate a focus on M&A activity, with new language added in the 2025 10-K that was absent in previous filings. The company's workforce has expanded significantly, with 13,757 full-time employees at fiscal year-end, a 30% increase from 10,562 employees a year earlier. This growth aligns with the company's impressive 83% revenue growth over the last twelve months. Manufacturing roles now represent 87% of the total headcount, up from 82% previously, showcasing a 37% quarterly increase. In an effort to optimize costs, Lumentum has sold two buildings at its San Jose headquarters and consolidated all employees into a single facility. CEO Michael Hurlston has emphasized the importance of a lean cost structure. Total purchase obligations at year-end reached $2.596 billion, a 45% increase year-over-year. Lumentum's recent financial results have exceeded expectations, with revenue and earnings per share surpassing consensus estimates by 2% and $0.26, respectively. The company's guidance for the first quarter also came in above expectations, with projected revenue and earnings per share increases of 8% and $0.51, respectively. This positive performance has led to adjustments in price targets and ratings by various analyst firms. Needham maintained a Buy rating with a target of $1,040, highlighting strong growth in AI optics. Mizuho raised its target to $1,140, driven by robust demand for AI infrastructure. TD Cowen increased its target to $820, retaining a Hold rating due to strong execution. BofA Securities lowered its target to $1,000, citing valuation concerns but raised earnings estimates for future years. Morgan Stanley also raised its target to $1,000, expressing optimism about the company's margin outlook.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}